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2Abstract
In order to address the problem of poor quality information available to health care providers
today, McClellan and Staiger (1999) developed a new method to measure quality, which addresses
some key limitations of other approaches. Their method produces quality estimates that reflect
diﬀerent dimensions of quality and are able to eliminate systematic bias and noise inherent in these
types of measures. While these measures are promising indicators, they have not been applied to
other conditions or health systems since their publication. This paper attempts to replicate their
1999 method by calculating these quality measures for English Hospitals using Hospital Episode
Statistics for the years 1996 –2008 for Acute Myocardial Infarction (AMI) and Hip Replacement.
Using the latent outcome measures calculated previously, Vector Autoregressions (VARs) are used
to combine the information from diﬀerent time periods and across measures within each condition.
These measures are then used to compare current and past quality of care within and across NHS
Acute Trusts. Our results support that this method is well suited to measure and predict provider
quality of care in the English setting using the individual patient level data collected.
Keywords: Measuring Quality; Vector Autoregressions; Health.
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4 1 Introduction
1 Introduction
The desire to measure the quality of hospital care dates back to the advent of medicine
itself. Yet, the measurement of hospital quality is no easy feat. Health care is complex,
multidimensional and the link between clinical practice and patient outcomes is often
tenuous at best. Many hurdles face those who attempt to measure quality starting with
the seemingly simple task of defining it. As far back as ancient Greece, the challenge in
defining quality of care resulted in using list of attributes, categories or features to aid
in its conceptualizations. The ancient civilizations of Egypt and Babylon recognized that
poor quality care can lead to harm, and good quality care to the absence of harm, however
still struggled with a better way to measure it than simply focusing on the final outcome
of care (Reerink, 1990). Indeed, up until the pioneering work of Nightingale, Codman and
Donabedian, the notion of quality of care while very real in terms of being recognized and
appreciated, was a mystery in terms of how to palatably define or measure it.
The first proponents of routine clinical outcome measurement were Florence Nightingale
(circa 1860) and Ernest Codman (circa 1900). Nightingale pioneered the systematic and
rigorous collection of hospital outcomes data in order to understand and improve perfor-
mance. While Codman advocated the “end results idea”, essentially the common sense
notion of following every patient treated for long enough to determine whether their treat-
ment was successful, and if not to understand and learn from the failures which occurred.
Unfortunately, political and practical barriers prevented both these ideas from becoming
fully adopted until the last twenty years. Currently, quality of hospital care is often con-
ceptualized with regards to the performance in diﬀerent domains, and in its measurement
indicators range beyond clinical outcomes, such as clinical process measures and resource
utilization measures. Avedis Donabedian, whose name is synonymous with quality mea-
surement, advocated the measurement of structure process and outcome rather than the
use of only outcomes to measure quality. He argued that “good structure increases the
likelihood of good process, and good process increases the likelihood of good outcome”
(Donabedian, 1988). Indeed many of the indicators used for quality measurement are
often thought of in terms of this framework, and increasingly quality management policies
use combinations of the three types of indicators.
Although clinical outcome measures are the gold standard for measuring eﬀectiveness in
health care, their use can be problematic, for example if the outcomes cannot realistically
be assessed in a timely or feasible fashion, or when trying to understand the contribution of
health services to health outcomes. Thus many health services performance initiatives use
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measures have certain distinct advantages, for example, they are quicker to measure, and
easier to attribute directly to health service eﬀorts (Brook et al., 1996). In addition they
are commonly considered a better measure of quality as they examine compliance with
what is perceived as best practice. However, they may have less value for patients unless
they are related to outcomes, and may be too specific focusing on particular interven-
tions or conditions. Moreover, process measures may ultimately ignore the eﬀectiveness or
appropriateness of the intervention and pre-judge the nature of the response to a health
problem, which may not be identical in all settings, such as for patients who have mul-
tiple morbidities Klazinga (2011). In recent years another important development in the
assessment of health service performance has been the growing use of patient reported
outcome measures. These type of measures typically ask patients to assess their current
health status, or aspects of health problems (?). In England, the routine use of Patient
Reported Outcome Measures (PROMS) is growing, with wide-scale adoption in the NHS
from 2009 for certain elective procedures.
However, amongst these diﬀerent measures and dimensions, clinical outcome measures
arguably carry the most weight as they are often the most meaningful for stakeholders
and more clearly represent the goals of the health system. Even Donabedian himself con-
cluded that, “outcomes, by and large, remain the ultimate validation of the eﬀectiveness
and quality of medical care” (Donabedian, 1966). In the past decades, many industrial-
ized countries have invested large amounts in the development and routine collection of
hospital outcome indicators. Indicators are being developed, tested and used in countries
such as Austria, Finland, Spain, Italy, France, Germany, Australia, the UK and the US,
where administrative databases and medical records are able to provide large-scale sources
of individual patient level data. These databases allow researchers to easily and relatively
cheaply calculate hospital-specific mortality rates which often serve as outcome-based mea-
sures of quality. It is easy to see why this type of measure is desirable. A simple indicator
that allows the identification of ‘good’ and ‘bad’ hospitals can serve as instruments to
direct policy and or to inform patient decisions. Indeed for some conditions, routinely
available data or this sort has been shown to be as good a predictor of death as some
expensive clinical databases (Aylin et al., 2007).
As measures of health outcome are increasingly used to inform policy, statistical re-
searchers have made eﬀorts to address some of the methodological issues associated with
them. For example, it is well known that a patient’s outcome will be influenced by the
severity of their condition, their socio-economic status as well as the resources allocated
to their treatment. In such cases, it is critical to employ methods of risk adjustment
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when using and comparing indicators to help account for these variations in patient pop-
ulations. Failure to risk adjust outcome measures before comparing patient performance
may result in misinterpretation of data which can have serious implications for quality
improvement and policy (Lisa I Iezzoni, Lisa I Iezzoni). Typically, some sort of risk ad-
justment technique is employed to address these attribution problems, and control for the
other influencing factors. However, many diﬀerent risk-adjustment mechanisms exist, and
are applied diﬀerently by diﬀerent users (Iezzoni, 1994). Thus risk-adjusted measures may
not always be comparable with one another (Iezzoni et al., 1996).
Hospital standardized mortality ratios (HSMR) are common risk-adjusted measures used
to evaluate overall hospital mortalities. Initially developed by Jarman (Jarman et al.,
1999), HSMRs compare the observed numbers of deaths in a given hospital with the
expected number of deaths based on national data, after adjustment for factors that aﬀect
the risk for in-hospital death, such as age, diagnosis and route of admission (Shojania
and Forster, 2008). However, despite their prolific use, many authors express concerns
as to the degree of true quality information these indicators hold and implore users of
this information to exercise caution in drawing conclusions from them (Birkmeyer et al.,
2006; Dimick et al., 2004; Lingsma et al., 2010; Mohammed et al., 2009; Normand, Wolf,
Ayanian, and McNeil, Normand et al.; Powell et al., 2003; Shahian et al., 2010). In part,
these concerns represent skepticism about how good risk adjustment techniques are at
controlling for diﬀerences in for case mix or chance variation. But also, mortality may not
always be a valid indicator of quality (Lisa I Iezzoni, Lisa I Iezzoni; Shojania and Forster,
2008). For, even when outcome measures are risk adjusted they still run the risk of not
accounting for factors that cannot be identified and measured accurately.
Indeed, measures of risk may not be uniformly related to patient outcomes across all
hospitals. Certain systematic factors which bias results when these diﬀerences are not
taken into account. Mistaking such errors for diﬀerences in quality is known as “case-
mix fallacy”. Systematic errors of these sort will lead to erroneous conclusions concerning
a variables true value. For example, patterns of use of emergency services may indicate
higher degrees of illness in some areas, but poor availability of alternative services in others
(Wright and Shojania, 2009). It would me misleading to adjust the data across hospitals
according to only one of these assumptions. Mohammed et al. (2009) find systematic
associations between hospital mortality rates and the factors used to adjust for case-mix in
English Dr. Foster data. Thus, using these measures for case-mix adjustment may actually
increase the bias that they are intended to reduce (Lilford et al., 2007; Powell et al., 2003).
In these cases standardized mortality ratios, or other risk-adjustment methods may also be
misleading. In order to avoid these types of errors it is critical that data collection methods
7are carefully designed and implemented (Terris and Aron, 2009). Most recently Shahian
et al. (2010) present evidence suggesting that the methodology used to calculate hospital
wide mortality rates is instrumental in determining the relative ‘quality’ assigned to a
particular hospital. The authors note that rather than suggesting a particular preferred
technique for the calculation of hospital mortality, they call into question the very concept
of the measurement of hospital-wide mortality.
Moulton (1990) notes that using aggregate variables, such as average death rates, in com-
bination with individual observations by trust or site to determine relationships through
regressions or other statistical models runs the risk of producing downwards biased stan-
dard errors, and possibly exaggerating the significance of certain eﬀects based on spuri-
ous associations. Moreover, while some deaths are preventable, or more dependent on
treatment, it is not sensible to look for diﬀerences in preventable deaths by comparing
all outcomes from one provider. Focusing on mortality rates associated with procedures
where the quality of care is known to have a large impact on patient outcomes, such as
those that are heavily dependent on technical skill, is in fact more informative (Lilford
and Pronovost, 2010).
Indeed, focusing on certain conditions could be considered an extreme form of risk adjust-
ment, where measures focus only on particular conditions, rather than creating organiza-
tion wide outcome measures. Surgical mortality rates for specific conditions or procedures
have become more popular as they are able to identify key areas where health system qual-
ity is more likely to influence outcomes, and where medical progress has been instrumental
in improving outcomes. Popular outcome indicators of this sort are 30-day mortality rates
for acute myocardial infarction (AMI) and Stroke. Better treatment of AMI in the acute
phase has led to reductions in mortality (Capewell et al., 1999; McGovern et al., 2001).
The last few decades have seen a dramatic change in care for AMI patients (Klazinga,
2011) first with the introduction of coronary care units in the 1960s (Khush et al., 2005)
and then with the advent of treatment aimed at restoring coronary blood flow in the 1980s
(Gil et al., 1999). Aside from the contributions from medical technology, improved pro-
cesses have also contributed to the improvement in outcomes. Research showed that the
time from AMI occurrence to re-opening the artery is a key driver of prognosis, and since
care processes were changed radically. It is now common for emergency medical personnel
to administer drugs, such as aspirin, during patients transport to hospital and emergency
departments have instituted procedures to ensure that patients receive definite treatment
with thrombolysis or catheterisation within minutes of arrival Klazinga (2011). Moreover
the proven link between identified care processes and patient outcomes, for conditions such
as AMI, allow researchers to be more confident in making judgements about quality and
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the end result of care. Indeed, there has been considerable work that has used AMI as
a proxy for quality both in England (Bloom et al., 2010; Propper et al., 2004, 2008) and
internationally (Kessler and McClellan, 1996, 2011; McClellan and Staiger, 1999; Shen,
2003).
The Organization for Economic Co-operation and Development (OECD) Health Care
Quality Indicators (HCQI) project, initiated in 2002, which aims to measure and compare
the quality of health service provision in the diﬀerent countries identifies key quality vari-
ables that can be used at the acute care level1. These indicators include case-fatality rates
for AMI and Stroke (OECD, 2010). The Agency for Healthcare Research and Quality in
the US, identified seven operations for which they recommended surgical mortality as a
quality indicator: Coronary Artery Bypass Graft (CABG) surgery, Repair of Abdominal
Aortic Aneurysm, Pancreatic Resection, Esophageal Resection, Pediatric Heart Surgery,
Craniotomy and Hip Replacement (Dimick et al., 2004). However, even in cases where
there is an established link between treatment and quality, it is not necessarily the case
that surgeries are performed frequently enough, in all hospitals, to reliably identify hos-
pitals with increased mortality rates. Indeed, Dimick et al. (2004), attempted to identify
how many hospitals had an appropriate sample size to determine quality based on these
seven conditions. They found that apart from CABG surgery, the remainder of operations
for which surgical mortality was advocated as a suitable indicator were not performed
frequently enough to make valid assessments of quality. Indeed further work on the re-
lationship between hospital volumes and outcome indicate that mortality rates are poor
measures of quality when small numbers of procedures are performed, unfortunately most
procedures are not performed frequently enough to allow valid assessment of procedure-
specific mortality at the individual hospital level (Birkmeyer et al., 2002). Indeed, most
observed variation across hospitals and across time is actually, as a consequence, from
random variation (good or bad luck) and does not reflect meaningful changes in quality
(Dimick and Welch, 2008).
Another common outcome measure at the hospital level are readmission rates. The mea-
sure has become increasingly popular despite the fact that it cannot always be attributed
to the quality of care delivered by the hospital. Indeed, McClellan and Staiger (1999) note
that high readmissions may be easily misinterpreted as indicators of poor quality when
in some cases they may indicate good quality treatment of severe patients. Moreover,
1 As the HCQI project is concerned with overall health system quality it also identifies suitable qual-
ity indicators in other health system domains, including patient safety, health promotion, protection
and primary care, patient experiences, cancer care and mental health care. For more information see
http://www.oecd.org/health/hcqi.
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(primary care), behavioural factors (poor adherence), or even the result of good quality
care; as hospital technology improves patients may survive, but with worsened morbidity
and subsequent episodes of hospital readmission. Benbassat and Taragin (2000) conclude
that readmission indicators are not good measures of quality of care for most conditions,
as there is large variation in the percentage of the indicator that can be attributed poor
quality care. Their own study using reports of diﬀerent readmission indicators for various
conditions indicated a range between 9%– 50%. They note that readmissions for specific
conditions, such as Child Birth, Coronary Artery Bypass Grafting and Acute Coronary
Disease as well as approaches that ensure closer adherence to evidence based guidelines,
may be more appropriate.
However, after initial use in the US, there are now a growing number of European countries
that measure readmission rates more systematically as a health service outcome Klazinga
(2011). A recent literature review conducted by Fischer et al, (2010), indicated that of
the 360 studies reviewed which used readmission rates as an outcome indicator, only 23
focused on the validity of the indicator and only 14 looked at the specific source of data
used to calculate the indicators. The authors concluded that routinely collected data on
readmissions alone is most likely insuﬃcient to draw conclusions about quality. Some of
the major problems linked to this conclusion was evidence of inaccurate and incomplete
coding of the indicator, and little evidence to indicate that readmissions are related with
quality of care carried out.
While investigating mortality and readmission rates by diﬀerent condition may allow a
clearer relationship between outcome and quality of care, other challenges such as random
error data quality still persist. Powell et al. (2003) note that variations in outcome will be
influenced by change variability which can manifest itself in Type 1 or Type 2 errors as well
as data quality. Both these issues are important, and while the former can be accounted
for to some degree using statistical tools the later can seriously undermine conclusions
made using the data. The best way to reduce the likelihood of both these types of errors
is to have more data, or more precision in the way they are collected. As routine data
collection mechanisms are still being developed and improved there is no way to completely
avoid this issue. Yet, as Spiegelhalter et al. (2002) note it would be advantageous to have
better data on morbidity collected, as mortality data is in most circumstances suﬃciently
rare, and thus of limited value in monitoring. Regardless, known limitations in the data
should always be made explicit when it is used.
Over the past two decades, much empirical research has been done to create improved
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adjustment mechanisms to make the best use of this information (Iezzoni, 2003). As more
organizations begin to use performance systems to make judgements about health service
quality and support decision making, more work has been concerned with methodological
techniques that can be used to create suitable profiles of provider quality (Landrum et al.,
2000). Diﬀerent statistical techniques have been used to this end, investigating one di-
mension of care, including Bayesian hierarchical regression models (Normand et al., 1997;
Christiansen and Morris, 1997) and maximum likelihood estimates (Silber et al., 1995).
These models control for diﬀerences in cases per hospital, thus reducing the noise which
may produce large diﬀerences between observed and expected mortality between hospitals
with diﬀerent sample sizes — due primarily to sampling variability.
However, as quality is multidimensional, this type of focus will limit the focus of compar-
ison across providers, and result in misleading results. However, reporting on too many
diﬀerent types of indicators may create confusion or overwhelm users of performance in-
formation, when there are contradictory indicators or simply too much information. So
called composite measures, or aggregated measures, may address some of these problems.
However there is often much controversy surrounding them because of the methods re-
quired to construct them which often involve weighing diﬀerent aspects of performance.
Yet, diﬀerent methodological studies have been undertaken to try to find suitable methods
to address these issues (Landrum et al., 2000).
Latent variable models have been used to account for the correlation among performance
measures and to measure the quality of providers. This type of methodology assumes an
unobservable (latent) trait, such as quality, contributes to the attainment of an ultimate
outcome. Correlation among diﬀerent measures is induced by variability in the latent
trait of any one provider, which represents the summary of the unobserved quality they
are able to deliver (Landrum et al., 2000). Originally these types of models were used in
psychology research (Bentler, 1980; Cohen et al., 1990), but have been applied to many
disciplines, including economics where they have been used to measure areas that are not
directly observable, such as quality of life Theunissen et al. (1998). One of the advantages
to using this methodology is that it can deal with multidimensionality of data, as it is able
to aggregate a large number of observable variables to represent an underlying concept.
Previous work (Papanicolas and McGuire, 2011) has used this approach to measure the
quality of diﬀerent English NHS hospitals in providing services over the period 1996 –2008
for seven diﬀerent conditions. However, the variability present in latent measures, or in
our case in latent quality across providers, will include both a systematic component and
a random component. The former can be explained by provider specific covariates and the
latter by chance. While the systematic components will also include measures of quality,
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they may also include other systematic diﬀerences that contribute to outcome, such as
deprivation or severity, which may bias the measures (Mohammed et al., 2009). Such bias is
referred to as systematic error, as discussed previously. In order to correct for these biases,
as well as some of the noise still present in the estimates, and create better measures of
quality McClellan and Staiger (1999) proposed using multivariate autoregression methods.
We use this method to evaluate quality for English hospitals using English patient level
data. Their method uses vector autoregressions (VARs) to capture dynamic interactions
in the time series and across measures. This step allows information from the dynamic
interactions of outcomes over time and across dimensions to be used to filter out more of the
noise captured by the measures, and also use the time series and cross sectional information
contained in the estimates to further adjust them. Moreover, the VAR methodology is
commonly used for forecasting, and thus can be used to predict and forecast hospital
quality extremely well. This chapter reviews the entire methodology and uses it to replicate
the McClellan and Staiger (1999) quality measures for English hospitals. These models
are able to create smoothed out hospital rates of mortality and complications over time
as well as to forecast future performance. This paper applies the McClellan and Staiger
(1999) technique to our previously estimated latent estimates calculated in Papanicolas
and McGuire (2011) and assesses the performance of the two measures in order to consider
the advantages and disadvantages of the diﬀerent methodologies.
2 Background
In health economics, and many other areas of applied economics, we face problems of
endogeneity amongst dependent and independent variables. Endogeneity can occur in
cases where there is a two-way influence between the independent and dependent variables.
This influence can arise from autoregression with autocorrelated errors, omitted variable
bias, simultaneity between variables as well as measurement and/or sample selection error.
Diﬀerent methodological techniques have been adopted to deal with this issue, such as
instrumental variable (IV) methods, simultaneous equation models, non-linear techniques
and GMM estimators, such as those outlined in Wooldridge (2002). Yet this problem
of endogeneity is not unfamiliar to economists who have come across the same problems
when attempting to explain the relationships among money, interest rates, prices and
output. In 1980, Christopher Sims (1980) championed the VAR approach which took
away many of the restrictions models impose and allowed the data to be modelled in an
unrestricted reduced form, where all variables are treated as endogenous. Predictions of
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the VAR model performed well, and so the technique has become popular in economics
despite critiques that it is atheorectical. The basic idea behind the model is to treat all
variables symmetrically, such that variables which that we are not confident are exogenous
are modelled as endogenous. This leads to an n-equation, n-variable linear model, where
each variable is explained by its own lagged values, plus the current and past values of the
other lagged variables. While VAR models are often used in macroeconomics to analyse
the relationship between diﬀerent policy tools, they have rarely been used in the area of
health economics.
This chapter considers using a VAR methodology similar to the McClellan and Staiger
(1999) method used to create better quality indicators that will control for these issues but
also use them to inform their estimation. The simplest form of a VAR is a first-order VAR
specification, VAR(1), where the longest lag length modelled is unity. Diﬀerent specifica-
tions of the model however are also able to incorporate more lags. Indeed identifying the
correct number of lags is important in order to specify the model correctly, and is likely
to influence the results. There are various tests available that indicate how many lags are
appropriate, including the Akaike information criterion (AIC) and the Schwartz criterion.
Stock and Watson (2001) also note that the VAR can come in three diﬀerent varieties, each
of which places diﬀerent restrictions upon the data being modelled, these are: reduced
form, recursive and structural. A structural VAR use theory to produce instrumental
variables that can test contemporaneous links between variables (Stock and Watson, 2001).
In practice structural VARs diﬀer considerably from their reduced form and recursive
counterparts, because of the restrictions placed upon the model. As we do not use this
type of VAR we will not go over it in detail2. A reduced form VAR expresses each variable
as a linear function of its own past values, the past values of all other variables being
considered and a serially uncorrelated error term. In our evaluation of quality a VAR(1)
model of this type would be represented by this simple system:
D30ht = α+ β1D30h(t−1) + β2D365h(t−1) + β3R28h(t−1) + β4R365h(t−1) + ￿D30ht
D365ht = α+ β1D365h(t−1) + β2D30h(t−1) + βR28h(t−1) + βR365h(t−1) + ￿D365ht
R28ht = α+ β1R365h(t−1) + β2D30h(t−1) + β3D365h(t−1) + β4R28h(t−1) + ￿R28ht
R365ht = α+ β1R365h(t−1) + β2D30h(t−1) + β3D365h(t−1) + β4R28h(t−1) + ￿R365ht . (1)
2 For an in-depth discussion on structural VARs see Stock and Watson (2001); Enders (2004).
13
Each equation in this system defines an outcome of interest and is estimated by Ordinary
Least Squares (OLS). The outcomes are 30-day mortality, D30ht, from the disease under
consideration, one-year mortality, D365ht, as well as 28-day readmissions R28ht and one-
year readmissions, R365ht . The subscript t denotes time in terms of years, and t − 1
occruances in the past year. The error terms represent the ‘surprise’ movements in the
variables after the past variables have been taken into account. If the diﬀerent variables
are correlated with each other, than the error terms in the reduced form model will also
be correlated across equations.
A recursive VAR constructs the error terms in each regression to be uncorrelated with one
another by including some contemporaneous values of the variables in the regression. So
our system from above, would be modified to look something like:
D30ht = α+ γ1D365ht + γ2R28ht + γ3R365ht + β2D365h(t−1)
+ β3R28h(t−1) + β4R365h(t−1) + ￿D30ht
D365ht = α+ γ1D30ht + γ2R28ht + γ3R365ht + β1D30h(t−1) + β2D365h(t−1)
+ β3R28h(t−1) + β4R365h(t−1) + ￿D365h
R28ht = α+γ1D30ht+γ2D365ht+γ3R365ht+γ3R365ht+β1D30h(t−1)+β2D365h(t−1)+
β3R28h(t−1) + β4R365h(t−1) + ￿R28ht
R365ht = α+ γ1D30ht + γ2D365ht + γ3R28ht + β1D30h(t−1) + β2D365h(t−1)
+ β3R28h(t−1) + β4R365h(t−1) + ￿R365ht . (2)
Equations (2) are not reduced form equations, for example D30ht will have a contempo-
raneous eﬀect on the other three quality variables, and they will have a contemporaneous
eﬀect on D30ht. This system can be better represented in matrix algebra, allowing the
VAR model to be represented in standard form (Enders, 2004). Again each regression
can be estimated by OLS, however if the right hand variables are not identical, because
some contemporaneous eﬀects are dropped than estimation by OLS will no longer provide
uncorrelated error terms. In this case a Seemingly Unrelated Regression (SUR) may prove
to be more eﬃcient.
As VARs involve current and lagged values of multivariate time series they are able to
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capture co-movements between variables that other models cannot. Thus, VAR models can
be very useful for data description. The McClellan and Staiger (1999) methodology uses
a reduced form VAR between the latent quality variables to understand the interactions
between the variables which are thought to be co-determined. Indeed by closely studying
the residuals and the coeﬃcients they are able to better understand just how persistent
quality is for various conditions. The relationship amongst diﬀerent quality indicators and
information about the variables which is important in their interpretation. Following this
analysis, the authors use the output produced from the VAR model to create smoothed
time-series estimates of each of the outcome variables that take into account the time-
series and cross-sectional variations they have identified. The empirical steps to this
process taken to replicate this process are reviewed in detail the following section before
the results are presented and discussed.
3 Methodology
Hospital performance over the period 1996 to 2008 is evaluated by a two step process, as
outlined by McClellan and Staiger (1999). The first step, undertaken in Papanicolas and
McGuire (2011), derives latent outcome measures at the hospital level (h) by estimating
patient level (i) regressions replicated below. The patient level regressions include hospital
fixed eﬀects (β) and a set of patient characteristics, ￿φX, known to influence outcomes
(age, gender, deprivation, co-morbidities, and elective or emergency treatment). The re-
gressions are run separately for each year (t) and outcome measure (k), and the hospital
intercepts, representing the mean value of outcomes of each hospital holding patient char-
acteristics constant across all hospitals, are extracted and used to create a new dataset at
the hospital level.
Y kiht = βqk1h +
￿
φXjht + uiht . (3)
As explained in detail in Papanicolas and McGuire (2011), the latent measures, β, describe
the rate of change in outcomes as explained by risk-adjusted hospital quality. This chapter
uses these latent measures in a VAR framework to create new quality measures which
describe, summarize and forecast hospital quality. The newly constructed dataset contains
Qh a 1× TK vector of the estimated latent hospital outcome for hospital h, adjusted for
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diﬀerences in patient characteristics, such that:
Qh = qh + ￿h ,
where qh is a 1 × TK vector of the true hospital eﬀects for hospital h, and ￿h is the
estimation error (which is mean zero and uncorrelated with qh). The variance of ￿h is
estimated from the patient level regressions (equation (3)) and is equal to the variance of
the regression estimates Qh, where Ωjh represents the covariance matrix of the hospital
eﬀects estimates for hospital h in year t. Or simply:
E(￿￿ht￿ht) = Ωht
E(￿￿ht￿ht) = 0, for t ￿= s .
Thus, the estimation problem McClellan and Staiger (1999) lay out is how to provide
estimates ofQh to predict qh. They propose creating a linear combination of each hospital’s
observed measures in such a way that minimizes the mean squared error of the predictions,
conceptualised as running the following hypothetical regression:
qkht = Qhtβkht + ωiht (4)
They note that equation (4) cannot be estimated directly, as q represents unobserved
performance and the optimal β varies by hospital and year. Thus, the measurement
challenge is to predict the true hospital eﬀect, q, from its noisy estimate Q. The idea is
to attenuate the coeﬃcient of Q towards zero, such that a prediction of q can be derived
that will reduce the noise without distorting the true eﬀect. This is a similar idea to a
smoothing technique as outlined, for example, in Titterington et al. (1985).
While equation (4) can not be directly estimated, the parameters of the hypothetical
regression can be estimated from the existing data. The minimum least squared predictor
is given by:
W (qh|Qh) = Qhβ ,
where
β = [E(Q￿hQh)]−1E(Q￿hqh) . (5)
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This best linear predictor can be calculated using the following estimates:
E(Q￿hQh) = E(q￿hqh) + E(￿￿h￿h) (6)
E(Q￿hQh) = E(q￿hqh) , (7)
where E(￿￿h￿h) is estimated using the individual patient level estimates of the covariance
matrix for the parameter estimates Qh, which we call Sh. Sh varies among hospitals.
E(q￿hqh) can be estimated by E(Q￿hQh − Sh) = E(Q￿hqh). Plugging these estimates into
equation (5) allows the calculation of the desired least squares estimates, such that:
qˆht = Q[E(Q￿hQh)]−1E(Q￿hqh) = Qh[E(q￿hqh) + E(￿￿h￿h)]−1E(q￿hqh) . (8)
Using estimates (6)and (7), the R-squared statistic can also be calculated, based on the
least squared formula.
Estimation of equation (8) provides the basis for the second step of the methodology,
undertaken in this chapter. McClellan and Staiger (1999) coin these estimates ‘filtered
estimates’ as they optimally filter out the estimation error of the observed quality mea-
sures. They note three attractive properties of the filtered estimates. First, that allows
information for many years and diﬀerent indicators to be combined in a systematic man-
ner. Second, by nature of their construction, these estimates are optimal linear predictors
for mean squared error. Finally, the estimates are simple to construct using standard
statistical software.
Given the time-series nature of the data, information of the performance in each hospital
eﬀect over time is used to better predict and further forecast the outcome measures. Using
a VAR model, further structure is imposed on the filtered estimates, by assuming that
each performance measure - given its past performance plus a contemporaneous shock -
can be correlated across the diﬀerent outcome measures. Thus a first order VAR model
for qht(1×K) is estimated, where:
qht = qh,t−1Φ+ vht . (9)
Z = V (vht) the (K ×K) variance matrix of the residuals, and Γ = V (qh(t=1)) the (K ×
K) initial variance matrix from the first year of the data sample are also estimated. Φ
represents a (K × K) matrix containing the estimates of the lag coeﬃcients. The VAR
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structure implies:
E(Q￿hQh)− Sh = E(q￿hqh) = f(Φ, Z,Γ) . (10)
Using the parameters estimated from the VAR model we are able to estimate equation
(10), using the Broyden algorithm in eViews to estimate non-stochastic predictions, or the
‘filtered outcome measures’.
The above analysis is estimated using a large pooled cross section that spans over many
individuals and providers. The first part of the analysis, reviewed in detail in Papanicolas
and McGuire (2011), is performed using the statistical package STATA, the remainder
of the analysis is undertaken in eViews, which includes more options to perform time-
series analyses, and especially the VAR model. The size and amount of information on
each patient and provider allows us to avoid many of the technical and methodological
challenges presented in time series analysis.
4 Data
Similar to Papanicolas and McGuire (2011), the data used in this paper is Hospital Episode
Statistics (HES) accessed through Dr. Foster. Hospital episode statistics (HES) contain
records for all NHS patients admitted to English hospitals in each financial year (April 1
to March 31), with information on all medical and surgical specialties, including private
patients treated in NHS hospital trusts. Diagnosis of patients are coded using ICD-10 (in-
ternational statistical classification of diseases, tenth revision) codes while procedures use
the UK Oﬃce of Population Censuses and Surveys classification (OPCS4). The data avail-
able in the HES database contains patient characteristic data (e.g. gender, age), clinical
information (e.g. diagnoses, procedures undergone), mode of admission (emergency, elec-
tive), outcome data (mortality, readmission, discharge location) as well as details on the
amount of time spent in contact with the health system (waiting times, date of admission,
date of discharge) and details of which hospital the patient was treated in.
Data on gender and age are used as explanatory variables in the analysis, as is a variable
indicating whether the treatment undergone was an elective procedure. The Charlson co-
morbidity index which predicts the 1 year mortality for a patient who may have a range of
co-morbid conditions was used to control for severity of patients. This index is constructed
by assigning a score to each condition depending on the risk of dying associated with it,
and summing these scores up (Charlson et al., 1987). Finally, socio-economic status was
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measured using the Carstairs index of deprivation. This index is based on four census
indicators: low social class, lack of car ownership, overcrowding and male unemployment,
which are combined to create a composite score. The deprivation score is divided into
seven separate categories which range from very low to very high deprivation.
This paper analyses data provided for the financial years 1996 –2008, for the conditions of
Acute myocardial infarction (AMI) and Hip Replacement. The data for these conditions
was extracted based on the ICD-10 and OPCS 4.3 classification codes indicated in Table
1. Due to problems with the sample sizes for some of the years before 2000 for AMI these
years were not included in the analysis. Moreover, any hospital trust that had less than
10 admissions throughout the entire period of analysis was dropped from the analysis.
Moreover, any primary care trusts, private trusts acting as NHS providers and social care
trusts were also excluded. For the sample of patients admitted with AMI, only emergency
admissions were examined, and only for patients with a length of stay greater than two
days.
This paper builds on the methods used in Papanicolas and McGuire (2011) which used
individual patient mortality rates and readmission rates at diﬀerent intervals to contract
latent outcome measures at the hospital level, as outlined in the methodology section
above. These latent measures are collected into a new data set at the hospital level,
distinguished by hospital identifiers and variables indicating the year of the measure. In
order to conduct the analysis described above all hospitals with missing years of data
are dropped from the sample. The sample size described in terms of number of hospitals
and average number of cases per hospital across all years are presented in Table 1. Data
were collected on seven conditions to assess the generalisability of the method. The seven
conditions are Acute Myocardial Infarction (AMI), Myocardial Infarction (MI), Ischemic
Heart Disease (IHD), Congestive Cardiac Failure (CCF), Stroke, Transient Ischemic At-
tack (TIA) and Hip Replacement. However, we reprot on two conditions in detail, AMI
and Hip Replacement, for the sake of brevity and as the general conclusion hold for all
the conditions. More detail can be obtained by contacting the authors.
Tab. 1: Summary statistics of the sample of hospitals included.
Condition ICD-10/ OPCS 4.3 codes Years
Analysed
Number of
Hospitals
Average Cases per
Hospital per year
AMI ICD-10: I21 2000 –2008 119 331
Hip OPCS4.3: W37-W39
W46-W48 W58
1996 –2008 120 332
19
5 Results
The methodology of this chapter uses VAR models to describe and summarise hospital
quality. By quantifying what is known about the diﬀerent dimensions of measured quality
and the time trend associated with the diﬀerent latent outcome measures. The results of
this chapter attempt to illustrate how well the filtered estimates perform at predicting in
sample hospital quality and forecasting out of sample hospital quality. This is done by
comparing the filtered measures to the latent measures diagrammatically as to visualize
how the methodology reduces the noise in the estimates, by measuring the signal to noise
ratio of the filtered estimates, and by estimating the goodness of fit measures of the
estimates. Each of these steps is explained in more detail below. This section shows that
in all of these areas the filtered estimates appear to be very good predictors and forecasts
of true hospital quality.
Of the seven conditions for which this analysis was conducted the results of AMI and Hip
Replacement are presented in this section, by condition. The methodology was also used to
study five other outcomes, namely Myocardial Infarction, Ischemic Heart Disease, Stroke,
Congestive Cardiac Failure and Transient Ischemic Attack, in order to test feasibility
across a wider range of conditions. As the methodology was applicable, and the results
were similar for all conditions we chose not to present all the results in this paper due
to the relatively large set of results which, if presented in totality, might obscure the
main objective of this article which was to present general operation of the methodology.
Suﬃce to say that with all conditions the general performance is similar. For each reported
condition, the first table of the results reports the VAR parameters of interest: the lag
coeﬃcients, the variance and correlation for the residuals to each eﬀect, and the initial
variance and correlation of the eﬀects in the first year of the sample. These are discussed
separately for each condition. All VAR models were tested for stability and passed unit
root tests with all roots lying inside the unit circle.
Initially the VAR parameters are estimated using the information on all five aggregated
outcome measures (i.e. the three mortality and the re-admission rates for all years in the
sample, separately for each condition). The VAR(1) specification is as given in equation
(9), and other specification of the model were tested with diﬀerent lag lengths, the inclusion
of additional lags yielded similar scores, sometimes marginally better, using the Akaike
information criterion and the Schwartz criterion. Given the small diﬀerence in scores we
chose to use the VAR(1) specification for all models as it fits the data relatively well and
makes the analysis more parsimonious and the models easier to interpret.
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The signal variance, which measures the underlying quality signal of each outcome measure
is one of the parameters which the VAR model is able to extract from the original hospital
data. These estimates can be used together with the estimates of the estimation error
in each measure, defined as Sh in equation (10) above, to estimate the signal-to-noise
ratio for each of the outcome measures, as specified in equation (11). For each condition
a figure is therefore included which plots the estimates of the ratio of signal variance to
total (signal plus noise) variance in the observed hospital outcome measures against the
number of cases treated in each hospital (the cases upon which this measure is based in
the first step of the analysis).
Signal/(Signal + Noise) = Vht/(Vht + Sht) (11)
This plot provides statistical information on the level of “true” signal in each of the quality
measures relative to underlying noise and indicates which performance measures have large
associated variances across the specific observed outcomes and across the relevant sample.
The methodology uses the VAR framework to further refine the latent outcome measures
estimated, as done in Papanicolas and McGuire (2011) by creating new ‘filtered’ measures
of quality which contain more information as, by using the underlying time-series structure
of the latent variables, they filter out more noise. The figures reported in each section
report the latent outcome measures used in the analysis together with the predicted (in
sample) filtered and forecasted (out of sample) filtered quality indicators for each condition.
The predicted filtered estimates are constructed for the entire time period using the latent
measures from the entire time period, while the forecasted indicators are constructed for
the entire time period using the latent measures only up to 2006. Thus, the last two
filtered measures are forecasted using existing data, but can be assessed as compared to
the existing measures for those years.
Each figure plots the latent and predicted filtered estimates constructed from the data in
four panels for four separate hospitals: small hospital (upper left), a large hospital (lower
right), and two midsize hospitals. These hospitals are not a random sample, but chosen
to illustrate the results in diﬀerent settings, and are the same hospitals represented in
the corresponding figures in Papanicolas and McGuire (2011). Each panel plots data for
a single hospital from 2000 through to 2008, apart from the figures for Hip Replacement
which plot the data on the larger sample available for that condition, from 1996 through to
2008. The figures plot two lines, a solid line indicating the aggregated outcome measures,
estimated from a linear model run separately by year controlling for patient characteristics
(see the data section above), and a long dashed line, indicating filtered outcome measures,
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estimated by a multivariate VAR framework including all the outcome-based measures.
The solid lines can be interpreted as absolute outcome diﬀerences, or risk-adjusted mortal-
ity rates. A value of 0.02 indicates that the hospital’s mortality was 2% above the average
hospital in that year, with negative values indicating lower mortality than average, con-
trolling for patient characteristics. The dashed lines are based on a multivariate VAR
model, thus incorporating all of each hospital’s data from 2000 –2006 (1996 –2006 for Hip
Replacement), and using this data to forecast the values for 2007 –2008. The two short
dashed lines indicate the 95% confidence intervals of the parameter estimates (long-dashed
line). These figures are discussed below, separately for each condition.
In order to assess the ability of the filtered estimates to predict variation in true hospital
eﬀects, McClellan and Staiger (1999) construct an R-squared measure that can be applied
to this setting, using the standard R-squared formula:
R2 = 1−
￿N
h=1 uˆ
2
h￿N
h=1 q
2
h
. (12)
As the purpose of this goodness of fit measure is to estimate how well the filtered estimates
minimize the mean square error of the prediction, the numerator should measure prediction
error, such that:
uˆ = q − qˆ .
Since q is not observed, estimates must be used for both the numerator and the de-
nominator. McClellan and Staiger (1999) propose using the estimate of E(q￿hqh) for the
denominator and E(qh − qˆh)￿(qh − qˆh) for the numerator. Both of these can be estimated
using estimates 6 and 7 above.
These R-squared measures are calculated for the predicted values, and presented separately
for each condition. Each table reports the results for predictions using diﬀerent amounts
of data, similar to the McClellan and Staiger (1999) analysis. The first column reports the
R-squared for predictions using all years of data for both outcomes, the second column uses
data from all years but only from the outcome being considered. The following columns
calculate the R-squared for predictions based on 3 years of data, and 1 year of data, for
both outcomes and one outcome respectively.
A similar goodness of fit measure is constructed in order to measure the accuracy of
the VAR model in forecasting outcomes. In order to compare the forecast to the actual
measurement, the model was estimated using data from 2000 –2006 (1996 –2006 for Hip
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Replacement) and used to forecast outcomes for 1 and 2 years ahead (2007 –2008). The
R-square measure for the forecasts, was thus used to measure the fraction of the true
hospital variation found in the aggregate measures that was successfully explained in the
forecasts:
R2 = 1−
￿N
h=1
￿
uˆ2h − Sh
￿￿N
h=1
￿
Q2h − Sh
￿ . (13)
In this measure the forecast error is estimated as:
uˆ = Q− qˆ
and Sh measures the variance of the OLS estimateQh. Thus the R-squared for the forecasts
estimates the amount of variance in the true hospital eﬀects that has been forecasted. This
R-squared measure can be negative if the forecasts lie out of sample. The expected R-
squared values are calculated for the forecasted values using the measure estimated for
the predicted values (equation (12)), the actual R-squared measures, based on actual
estimates (equation (13)) are also calculated. These R-squared measures for predictions
and forecasts are presented below, separately for each condition.
The final part of the results section (5.3), ranks the hospitals in the same using three
diﬀerent performance measures (raw, latent and filtered measures).This allows for a better
understanding of the diﬀerences between the indicators and can be useful in drawing
conclusions as to their applicability to policy.
5.1 AMI
The parameter estimates of basic model coeﬃcients in Table 2 indicate the eﬀect past
values of each outcome measure have on their own performance. The model suggests that
one-year hospital mortality, D365ht, is the most persistent of all four outcome indicators,
with a value of the coeﬃcient on its own lag of approximately 0.8. R28ht exhibits a weak
dynamic eﬀect, with a coeﬃcient of around 0.4, while D30ht and R365ht both show an
almost negligible dynamic eﬀect. The standard deviation of the residuals indicate about
6% variation in short term mortality rates, and long term readmission rates across hos-
pitals, while short term readmission rates vary by nearly 4% across hospitals. Long term
mortality rates however are subject to much wider variation at about 17% across hospi-
tals. The standard deviations from the year 2000 suggest that both readmission measures
and year-long mortality have an annual variation around 3 – 4%, however 30-day mortal-
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ity rates fluctuate more, varying around 10% annually. The correlation between variables
in the year 2000, indicates a negative association between the outcome measures 30-day
mortality, D30ht and short term re-admissions, R28ht. The correlation of residuals indi-
cates a similar negative association between D365ht and R365ht, and a positive association
between R28ht and R365ht.
Tab. 2: Estimates of AMI multivariate VAR(1) parameters for hospital specific eﬀects.
D30ht R28ht D365ht R365ht
D30h(t−1) 0.078627 -0.023861 0.582003 -0.330667
(0.04077) (0.02525) (0.07844) (0.04201)
[ 1.92840] [-0.94497] [ 7.41973] [-7.87205]
R28h(t−1) -0.299568 0.404420 -1.651768 0.478057
(0.05853) (0.03625) (0.11260) (0.06030)
[-5.11841] [ 11.1577] [-14.6699] [ 7.92850]
D365h(t−1) 0.166596 -0.052642 0.797091 -0.044305
(0.01356) (0.00840) (0.02608) (0.01397)
[ 12.2879] [-6.26978] [ 30.5604] [-3.17204]
R365h(t−1) 0.043576 0.012759 0.536484 -0.003055
(0.03673) (0.02274) (0.07066) (0.03784)
[ 1.18648] [ 0.56097] [ 7.59290] [-0.08073]
Residuals
S.D. dependent 0.057489 0.036205 0.172179 0.058462
Correlation of residuals (D30ht) 1.000000 -0.195636 0.281587 -0.272041
Correlation of residuals (R28ht) -0.195636 1.000000 -0.172637 0.478933
Correlation of residuals (D365ht) 0.281587 -0.172637 1.000000 -0.437937
Correlation of residuals (R365ht) -0.272041 0.478933 -0.437937 1.000000
Initial Conditions
S.D. dependent in 2000 0.095917 0.029137 0.038380 0.03838
Correlation with D30ht in 2000 - -0.5124 0.0335 0.0641
Correlation with R28ht in 2000 -0.5124 - -0.0304 0.0334
Correlation with D365ht in 2000 0.0335 -0.0304 - -0.0431
Correlation with R365ht in 2000 0.0641 0.0334 -0.0431 -
Sample (adjusted): 2001 2008
Included observations: 952 after adjustments
Standard errors in ( ) & t-statistics in [ ]
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Figure 1 presents the signal to noise ratio of the four AMI outcome measures. This is
calculated as specified by equation (11) using the signal variance estimated in the VAR
equation as well as the observed measurement error from the patient level equations.
The ratio estimates of the amount of signal variance to total (signal plus noise) variance
in the observed hospital outcome measures, and plots this ratio against the number of
cases treated in each hospital. What is immediately apparent from Figure 1 is the very
high signal to noise ratios, especially once the number of cases rises above 200, which is
indicative that the outcome measures are strong estimates of quality. Of the four measures,
the two mortality measures have the strongest signal, where year-long mortality is a better
predictor of performance than 30-day mortality due to the higher variance across hospitals
in the true eﬀects observed in Table 2. However, as the sample exceeds 300 patients,
the diﬀerence between the two indicators ratios begins to shrink, suggesting that both
indicators can be used to detect a large amount of the mortality-related quality diﬀerence
between hospitals. While, the readmission measures also have good signal to noise ratios,
and especially year-long readmissions, they are lower than the mortality measures. In the
larger hospitals the indicators do have relatively strong signals, but for the small hospitals
they remain, as might be expected given the smaller sample sizes, relative noisy measures
of performance.
Fig. 1: Signal to noise ratio for the four AMI outcome measures (year 2005).
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Figures 2 – 5 present the filtered AMI outcome measures (black dashed line) for selected
hospitals, together with their confidence intervals (red dotted lines), and the latent out-
come measures as derived in Papanicolas and McGuire (2011) (blue solid line). There are
two features of the filtered estimates that stand out when compared to the latent mea-
sures. The first is that, as expected, the filtered estimates move smoothly from year to
year, while the latent indicators are more erratic. The filtered estimates tend to be closer
to zero than the aggregated estimates, indicating their tendency to approach the average.
The other noticeable diﬀerence between the filtered and latent outcome indicators are the
confidence intervals which are much wider for the filtered measures than they were for the
latent variables as estimated in Papanicolas and McGuire (2011). Thus while the filtered
measures seem more consistent over time, the wider confidence intervals surrounding them
make it harder to interpret them with certainty as compared to the latent measures.
Fig. 2: Filtered and latent estimates for AMI D30ht for selected hospitals.
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Fig. 3: Filtered and latent estimates for AMI D365ht for selected hospitals.
Fig. 4: Filtered and latent estimates for AMI R28ht for selected hospitals.
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Fig. 5: Filtered and latent estimates for AMI R365ht for selected hospitals.
Table 3 indicates the R-squared estimates as calculated from equation (12) discussed
above. These are presented for the predictions made of the diﬀerent outcome measures,
using diﬀerent amounts of past data. The table indicates very high R-squared values for
all measures, suggesting that the filtered estimates are able to predict extremely well. In
all cases the predicted R-squared values suggest that the filtered estimates capture over
90% of the true variation across hospitals in the diﬀerent outcomes measures. Only for
one-year mortality are the estimates a bit lower, although even then they do not fall below
79%. Table 3 also indicates that the filtered estimates are able to predict just as well using
fewer years of data.
28 5 Results
Tab. 3: Summary of estimated prediction accuracy using alternative methods of signal extraction.
All estimates based on the VAR(1) model from Table 2.
Expected R2 prediction based on:
All 8 years 3 most recent years Concurrent year
All
outcomes
Same
outcome
All
outcomes
Same
outcome
All
outcomes
Same
outcome
D30ht
2004 0.993171 0.993224 0.993237 0.993246 0.994526 0.994452
2006 0.979275 0.979259 0.981738 0.981795 0.979818 0.979875
D365ht
2004 0.891798 0.892396 0.891843 0.891521 0.990980 0.990974
2006 0.981158 0.980648 0.916352 0.916693 0.796221 0.796244
R28ht
2004 0.996880 0.996899 0.996901 0.996891 0.997927 0.997931
2006 0.996920 0.996921 0.997074 0.997065 0.997650 0.997664
R365ht
2004 0.991736 0.991746 0.991792 0.991701 0.992516 0.992544
2006 0.989215 0.989353 0.989767 0.989848 0.991058 0.991133
The R-squared values for the outcome forecasts are presented in Table 4. The expected R-
squared values are derived using equation (13) and represent how well the forecasts are able
to predict the true values. The actual R-squared values indicate how well the predictions
fit the data when using a full sample. Both the actual and the expected R-squared values
are very high. While the expected R-squared values are lower than the actual R-squared
values the diﬀerence is very small, and never more than14%. This indicates that the
forecasts are also able to predict the true values extremely well for up to two years after
the end of the data set. The results are also presented for a VAR(2) specification of the
model, and are almost identical to the VAR(1) results. This indicates that the forecast
performance is not sensitive to the lag choice specified for this VAR model.
Tab. 4: Summary of forecast accuracy using alternative forecasting models. Forecasting 2006 –
2008 values using data from 2000 –2006.
All outcomes Same outcome All outcomes Same outcome
VAR(1), forecasting with VAR(2), forecasting with
D30ht
2007(expected) 0.997908 0.997619 0.998164 0.998201
2007 (actual) 0.9939783 0.9940615 0.9927514 0.9927658
2008(expected) 0.994683 0.994478 0.997798 0.997928
2008 (actual) 0.9489663 0.9486998 0.9446982 0.9446459
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All outcomes Same outcome All outcomes Same outcome
D365ht
2007(expected) 0.973235 0.971065 0.979825 0.979843
2007 (actual) 0.9774626 0.9764693 0.9616151 0.9613662
2008(expected) 0.968023 0.96491 0.976735 0.979905
2008 (actual) 0.9759809 0.9745514 0.9708943 0.9708727
R28ht
2007(expected) 0.97878 0.979752 0.993951 0.992514
2007 (actual) 0.9911799 0.9912462 0.9912541 0.9912401
2008(expected) 0.924943 0.912794 0.953368 0.957072
2008 (actual) 0.993593 0.9936331 0.9943355 0.9943442
R365ht
2007(expected) 0.890177 0.890824 0.895657 0.867804
2007 (actual) 0.9843904 0.9845041 0.9845231 0.9842737
2008(expected) 0.846979 0.84891 0.828721 0.841011
2008 (actual) 0.980951 0.981266 0.9836124 0.9833608
5.2 Hip Replacement
The parameter estimates of the basic model run for Hip Replacement are presented in
Table 5. The estimates suggest that D365ht is persistent over time, but that the other
quality indicators being considered are not. The lag coeﬃcient of D365ht is almost 0.6,
as compared to lag coeﬃcients of about 0.2 for R28ht and R365ht, and about 0.01 for
D30ht. The variance of initial conditions indicates a standard deviation of about 2%
across hospitals for D30ht, 3% for R28ht, 4% for D365ht and 5% for R365ht. Similarly
the variance of their residuals shows an annual standard deviation of 1% for D30ht and
D365ht, 3% for R28ht and 4% for R365ht. The correlation coeﬃcients amongst indicators,
and amongst residuals, indicate a high positive correlation between R365ht and R28ht,
and a weak positive correlation between D30ht and D365ht. There is a positive correlation
between the residuals of D365ht and R28ht, while the correlation coeﬃcient amongst these
two indicators in the year 2000 is low and negative. The opposite is true for the pair
D365ht and R365ht which have a negative correlation in the year 2000, but a low positive
correlation between their residuals. Finally there is a positive correlation between D30ht
and R28ht.
30 5 Results
Tab. 5: Estimates of Hip Replacement multivariate VAR(1) parameters for hospital specific eﬀects.
D30ht R28ht D365ht R365ht
D30h(t−1) -0.047351 -0.224300 -0.627994 -0.282623
(0.02543) (0.07851) (0.08952) (0.09652)
[-1.86231] [-2.85705] [-7.01536] [-2.92803]
R28h(t−1) -0.030140 0.312121 -0.359189 0.468140
(0.01479) (0.04567) (0.05207) (0.05615)
[-2.03789] [ 6.83480] [-6.89816] [ 8.33795]
D365h(t−1) 0.036579 0.058774 0.633914 -0.029772
(0.00686) (0.02119) (0.02417) (0.02606)
[ 5.32910] [ 2.77313] [ 26.2315] [-1.14255]
R365h(t−1) -0.016563 -0.045723 -0.039086 0.018910
(0.01098) (0.03390) (0.03865) (0.04168)
[-1.50871] [-1.34884] [-1.01124] [ 0.45373]
Residuals
S.D. dependent 0.011466 0.036723 0.049172 0.046638
Correlation of residuals (D30ht) 1.000000 -0.197193 0.262098 -0.250718
Correlation of residuals (R28ht) -0.197193 1.000000 0.350683 0.790476
Correlation of residuals (D365ht) 0.262098 0.350683 1.000000 0.149165
Correlation of residuals (R365ht) -0.250718 0.790476 0.149165 1.000000
Initial Conditions
S.D. dependent in 2000 0.019079 0.033392 0.044777 0.046217
Correlation with D30ht in 2000 - 0.3661 0.2470 0.1459
Correlation with R28ht in 2000 0.3661 - -0.1613 0.7196
Correlation with D365ht in 2000 0.2470 -0.1613 - -0.4921
Correlation with R365ht in 2000 0.1459 0.7196 -0.4921 -
Sample (adjusted): 1997 2008
Included observations: 1462 after adjustments
Standard errors in ( ) & t-statistics in [ ]
Figure 6 illustrates the signal to noise ratios of the observed hospital outcome measures
against the number of Hip Replacement cases treated in each hospital. For Hip Replace-
ment, the signal to noise ratios are quite high, indicating that the four outcome measures
are good indicators of hospital performance. Similar to the previous conditions, the signal
to noise ratio increases as more cases are included in the analysis, and the diﬀerences
between the four indicators begin to shrink. Yet, year-long mortality consistently has the
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strongest signal of the four conditions, despite not having as high a signal variance as it did
for AMI. While year-long readmissions have a higher signal variance than year-long mor-
tality (Table 5), they most probably have higher amounts in the variance of the estimation
error, causing them to perform the worst of the four measures.
Fig. 6: Signal to noise ratio for the four Hip Replacement outcome measures (year 2005) .
Figures 7 – 10 present the filtered Hip outcome measures, their 95% confidence inter-
vals and the corresponding latent outcome measures derived in Papanicolas and McGuire
(2011) for selected hospitals. The sample for Hip Replacement is longer than for AMI,
and so all figures present information back to 1996. Similar to the other two conditions,
the filtered estimates are smoothed averages of the latent measures, and the confidence
intervals are wider, again due to a limited number of hospitals available in the data. Also
similar to Stroke, the latent measure for the small hospital, upper left hand corner, is more
erratic than for the medium and large hospitals, thus making the filtered estimates useful
in terms of interpreting a trend over time.
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Fig. 7: Filtered and latent estimates for Hip Replacement D30ht.
Fig. 8: Filtered and latent estimates for Hip Replacement D365ht.
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Fig. 9: Filtered and latent estimates of Hip Replacement R28ht.
Fig. 10: Filtered and latent estimates of Hip Replacement R365ht.
Table 6 indicates the R-squared estimates for the predictions made for the Hip filtered out-
comes, using diﬀerent amounts of past data. The R-squared values for Hip are extremely
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high, indicating a near perfect prediction for all measures, even when using only one year
of data. Table 7 indicates the R-squared values for the outcome forecasts, estimated using
equation (13), and predictions estimated using equation (12). These are also near perfect
for both the forecasts and predictions, and both the VAR(1) and VAR(2) specifications.
This indicates that the model is able to forecast estimates as well as it is able to predict
them from a full set of data, regardless of the lag choice specified in the model.
Tab. 6: Summary of estimated prediction accuracy using alternative methods of signal extraction.
All estimates based on the VAR(1) model from Table 5.
Expected R2 prediction based on:
All 11 years 3 most recent years Concurrent year
All
outcomes
Same
outcome
All
outcomes
Same
outcome
All
outcomes
Same
outcome
D30ht
2004 0.999851 0.999851 0.999850 0.999852 0.999824 0.999829
2006 0.999856 0.999852 0.999860 0.999857 0.999840 0.999840
D365ht
2004 0.993021 0.992983 0.992833 0.992773 0.998047 0.998065
2006 0.994185 0.994248 0.991052 0.990711 0.982275 0.982161
R28ht
2004 0.998588 0.998589 0.998595 0.998593 0.998714 0.998706
2006 0.997845 0.997845 0.997835 0.997836 0.997967 0.997969
R365ht
2004 0.995829 0.995849 0.995807 0.995831 0.996284 0.996242
2006 0.993924 0.993940 0.993907 0.993959 0.995122 0.995136
Tab. 7: Summary of forecast accuracy using alternative forecasting models. Forecasting 1996 –
2008 values using data from 1996 –2006.
All outcomes Same outcome All outcomes Same outcome
VAR(1), forecasting with VAR(2), forecasting with
D30ht
2007(expected) 0.999837 0.9998281 0.9998208 0.9998139
2007 (actual) 0.9998575 0.9998609 0.9998577 0.9998588
2008(expected) 0.9997321 0.999688 0.9997113 0.9996896
2008 (actual) 0.9998561 0.999858 0.9998613 0.9998624
D365ht
2007(expected) 0.9968599 0.9970006 0.9963497 0.9963019
2007 (actual) 0.9869273 0.9871355 0.9848145 0.9850215
2008(expected) 0.9965712 0.9964086 0.9957694 0.9954451
2008 (actual) 0.9840067 0.9841068 0.9814323 0.9818322
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All outcomes Same outcome All outcomes Same outcome
R28ht
2007(expected) 0.9985577 0.9983832 0.9987864 0.9986095
2007 (actual) 0.9980288 0.998031 0.9980153 0.9980155
2008(expected) 0.9995171 0.9995244 0.999558 0.9995869
2008 (actual) 0.9767528 0.9767398 0.9767273 0.9767253
R365ht
2007(expected) 0.9989753 0.9989704 0.9990094 0.9990171
2007 (actual) 0.9928861 0.9929147 0.9931077 0.993055
2008(expected) 0.999464 0.9994054 0.999514 0.9994828
2008 (actual) 0.9878172 0.9878773 0.9880453 0.9880126
5.3 Comparison of Indicators
In this subsection, we are able to relate our findings to policy by ranking the hospitals in
the AMI sample using three diﬀerent indicators of performance for the year 2005. The
first indicator is an aggregated 30-day mortality rate as available in the raw data. The
second performance indicator is the latent 30-day mortality rate, while the third measure
is the filtered 30-day mortality rate estimated using the McClellan and Staiger (1999)
methodology. The hospitals are also ranked by the other outcomes and these are reported
in Appendix A due to space constraints. The year 2005 is presented as it is in the middle
of the sample and allows enough information to construct the filtered measures from,
however the R-squared values in the AMI section suggest that even with less data the
filtered measures are still good predictors. The outcomes are ranked only for AMI and not
the other conditions, as the results are very similar and do not provide further insight.
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Tab. 8: Rankings of 2005 AMI D30ht measures.
Ranking Mean D30ht Hospital Latent D30ht Hospital Filtered D30ht Hospital
Top 10
1 0.0521401 55 -8.417754 83 -2.490163 17
2 0.0532544 9 -5.088554 81 -2.113111 54
3 0.0536913 89 -5.00683 42 -1.934144 22
4 0.0594286 119 -4.887803 47 -1.651729 103
5 0.0645161 62 -4.834379 22 -1.651613 3
6 0.0681818 19 -4.648541 15 -1.608179 18
7 0.0681818 97 -4.089908 1 -1.47745 7
8 0.0684932 80 -4.078938 50 -1.438395 107
9 0.0758808 52 -3.924413 16 -1.425196 21
10 0.0774194 42 -3.834195 68 -1.343411 89
Bottom 10
110 0.1702128 12 2.985045 3 0.2998581 33
111 0.1727941 36 3.342186 7 0.3957789 118
112 0.1759531 96 3.580219 41 0.4082001 41
113 0.1787072 17 3.738158 89 0.4182017 99
114 0.19 53 4.557611 90 0.5266839 66
115 0.1901408 71 4.750142 17 0.5433974 38
116 0.1929825 41 5.562703 53 0.5688122 35
117 0.1987578 90 5.586496 71 0.9426492 27
118 0.2 66 18.70218 43 1.04961 9
119 0.3426574 43 28.97059 66 1.091938 56
Table 8 presents the top and bottom 10 hospitals as ranked by the three diﬀerent perfor-
mance measures together with the values of each measure. Each hospital is represented by
a number which has been randomly assigned to be its identifier. Figure 11 illustrates the
diﬀerent rankings for the first 15 hospitals in the sample. What is immediately apparent
from both Table 8 and Figure 11 is that depending on the indicator used the ranking of
hospitals changes substantially, although not always in the same direction. Some hospitals
go from a very high ranking to a very low ranking. Hospital 9 went from being ranked
second best to second worst when using the filtered measure to rank performance instead
of the raw aggregated mortality measure. Hospital 3 on the contrary, went from a very
low ranking, 96 to a very high ranking, 5. There are also cases where two measures seem
to be more similar to one another, but where rankings stay relatively consistent such as
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hospitals 11 and 15.
Fig. 11: Rankings of 2005 AMI quality measures for D30ht.
Figure 12 presents the full time series of the three diﬀerent performance indicators for
hospitals 3, 9, 11 and 15. This alternative presentation of the data can help to better
understand why the rankings are diﬀerent from one another. In the upper left hand
corner the trajectories of hospital 3’s indicators are presented. The mean raw mortality
only ranges between 0 and 1, as each patient is coded as either having died or survived.
When ranked according to this indicator, hospital 3 does relatively poorly coming in 96th
out of 119 in 2005. This indicator does not adjust for diﬀerences in patient characteristics,
such as co-morbidity or deprivation, while the latent measure does. When looking at the
performance of hospital 3 as reported by latent measure there is much more variation from
year to year. The year 2005 is the worst year in terms of hospital 3’s performance, and
the hospital is ranked 110 of 119. In all other years however, the hospital performs above
average. The third indicator, the filtered measure, is constructed using the information
provided throughout the time-series and from the other outcome measures. While the
filtered indicator does reflect hospital 3’s worsening performance over time, it smooths out
the year-to-year variation allowing for a more representative overall picture when singling
out one year. The performance ranking for hospital 3 using the filtered measure is 5 out
of 119, which is a huge diﬀerence from the latent measure but reflects the hospital’s above
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average performance in all the other years.
When looking at hospital 9 in the upper right hand panel, again the raw mortality has much
less variation than the other two indicators. Using this indicator hospital 9 ranks 2nd out
of the 119 in 2005. The latent measure adjusts for some of the patient diﬀerences through
time and shows a very diﬀerent picture of performance, with much larger year to year
variation. Performance as reported by this indicator starts out much worse than average
in 2000, improving in the years 2001 –2006, but worsening again after. In 2005 performance
is still above average, but adjusting patient characteristics, the ranking falls from 2 to 16.
The third indicator, the filtered measure, is constructed using the information provided
throughout the time-series and from the other outcome measures. Thus, the improvement
in performance is indicated, however not as sharply as by the latent measure, and never
so much that it results in above average performance. This adjustment causes the ranking
to drop down to 118.
Fig. 12: AMI D30ht quality indicators for selected hospitals.
Hospital 11 in the bottom right hand panel ranks 79 out of 119 when using the aggre-
gated raw mortality measure. However the latent variable indicates that when controlling
for patient characteristics performance varies considerably from year to year, sometimes
reaching very high levels above average, and others falling far below average. 2005 is one of
the years where performance is below average, and thus when ranked according to it does
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poorly coming 104th out of 119. The filtered indicator by definition provides a smoothed
out measure of average performance across time and incorporating the performance of the
other outcome measures. This is apparent from the diagram which shows less volatility
over time in the filtered indicator. Using this indicator the ranking falls down to 87th out of
119, which lies between the two other measures. Finally, when looking at the performance
of hospital 15 in the bottom right hand panel we see a similar result. The latent measure
shows much more erratic performance from year to year once it controls for all the patient
characteristics, and the filtered measure is able to summarize these into a much smoother,
consistent trend.
Overall, the analysis provides support for the following: Aggregate raw measures are un-
able to produce a consistent performance ranking of hospitals that controls for systematic
diﬀerences in patients case mix, such as deprivation or severity. The latent measures do
adjust explicitly for these diﬀerences, but exhibit year-on-year variation and therefore dif-
ferent rankings of hospital performance depending on the year selected, making it diﬃcult
to draw conclusions on overall hospital performance over time. The filtered measures are
able to summarize the information provided by the latent variable over time and consider
the performance of the other indicators alongside it, thus providing a much more consistent
picture of performance.
The largest diﬀerence in rankings is observed in hospitals treating fewer patients. Small
caseload leads to increased volatility in the raw mortality and readmission measures across
the years. While the latent measures control for systematic patient diﬀerences in hospitals,
the volatility due to small numbers remains. This finding was also reported in Papanicolas
and McGuire (2011), where latent estimates calculated for small hospitals always had the
most erratic performance measures from year to year. The filtered measures are better at
smoothing out the jumps from year to year as they combine all the information from the
time-series and across the other variables. Thus in these cases, the filtered measure will
be a better indication of performance in any one year.
6 Discussion
In their paper The Quality of Health Care Providers, McClellan and Staiger (1999) propose
a methodology with which to evaluate health care providers. Their framework is able to
tackle some of the main limitations inherent to quality measurement, allowing them to
create indicators which: integrate diﬀerent dimensions of quality into one measure, reflect
the multifaceted nature of performance; filter out much of the noise inherent to this type of
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measure as a result of the small number of patients treated and the large number of factors
which contribute to outcomes; and to eliminate much of the bias created from systematic
diﬀerences in patient mix which may result in variations in treatment. Their paper uses US
patient level data for elderly American’s suﬀering from heart disease to create performance
indicators at the hospital level. They are able to prove that the indicators they create
predict and forecast quality remarkably well, better than many existing methods.
Despite its advantages over traditional methods, this analysis has not been applied to
evaluate hospitals outside the US3, or for other conditions. This paper attempts to repli-
cate their analysis using English patient level data for a wider range of conditions. The
paper is also able to address some of the limitations acknowledged by the authors, due to
gaps in their data on patient co-morbidity, which can be used to create even more robust
indicators. Our results indicate that this method can be applied to other countries with
similar data, and when controlling for co-morbidity are able to produce indicators with
high prediction accuracy. However, in our application of this method to a diﬀerent setting
we are also able to identify other diﬃculties, which arise to do a smaller sample of hospitals
available in the English data as compared to the US data.
The first step of the methodology, creating latent measures of performance for each of the
outcomes of interest, is presented in Papanicolas and McGuire (2011). These latent mea-
sures serve essentially as risk adjusted measures of performance, as they are able to control
for exogenous patient characteristics such as age, gender, deprivation and co-morbidity.
They proved to be useful for detecting trends and comparing hospital performance to
their peers. When analysed more closely, to see what factors influenced performance, the
results indicated that many of the indicators are dynamic, and also related to one another.
This paper replicates the second step of the methodology which uses a VAR framework
that is able to incorporate the time series information, as well as the relationship to the
other outcome variables into new performance indicators. Both the VAR models, and the
indicators inform us on the performance of hospitals.
The results of the VAR models indicate which dimensions of hospital performance are
persistent across diﬀerent conditions, indicate how much they vary across hospitals and
over time, and provide insight as to their relationship with each other. The results for
all conditions suggest that of the four measures included in the model, year-long mor-
tality is the most persistent dimension of performance. In all conditions for which this
methodology was used, it suggested a strong dynamic presence for the year-long mortality
3 It has been applied to evaluate educational outcomes in the USA, for more information see Kane et al.
(2002).
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indicator. For most conditions, except Hip Replacement, this indicator also exhibits a
high standard deviation across hospitals, ranging from 20% to 5%. The high variation
associated with year-long survival most likely stems from a variety of factors outside the
provider’s influence, such as patient behaviour and lifestyle. Although the extent of this
influence will vary by condition.
The persistence of the 30-day mortality indicator varied considerably more by condition,
while it was quite low for AMI and Hip Replacement which are the results reported in
this paper. The variation of 30-day mortality across hospitals also varies considerably by
condition, and again was low for AMI, at around 6% and Hip Replacement, at around 1%.
Unlike our results, the McClellan and Staiger (1999) paper finds that 30-day mortality
is more persistent than year-long mortality for AMI, and that shorter term mortality is
more persistent than year-long mortality for IHD. This diﬀerence could be explained by
variations in the UK and US treatment pathways. It could also be linked to the diﬀerent
samples being analysed by the diﬀerent investigations; their analysis focused only on the
elderly while ours examined all patients. It may also be related to the fact that we were
able to adjust for patient co-morbidity which they did not have the data to do.
Similarly, previous analyses using the latent indicators in Papanicolas and McGuire (2011)
only identified a significant dynamic relationship between IHD and Hip Replacement for
year-long mortality, and a significant dynamic relationship for AMI, IHD, Stroke and Hip
Replacement for 30-day mortality. Given the performance of the filtered estimates on the
diﬀerent goodness of fit measures this could be related to the noise in the latent estimates
which obscure the ‘true’ quality eﬀect. It could also reflect the number of restrictions set
in the GMM model, which the VAR model does not apply.
Moreover, we mention in the results section that for this analysis the VAR(1) specification
was chosen for ease of interpretation and parsimony. However, diﬀerent specifications
were indicated as marginally better fits for the model by the Aikake and Swartz lag tests.
Yet, when tested with alternative specifications the results did not diﬀer substantially.
Moreover, the R-squared estimates calculated for a VAR(2) specification, as reported in
the results section, indicate similar results for all conditions, and in many cases do not
indicate improved fit. However, investigation for each condition could benefit from the
inclusion of more lags to create more robust predictions and forecasts, especially if there
is a longer time-series being analysed.
The readmission indicators are by and large less persistent indicators of quality as com-
pared to mortality. The coeﬃcients on the lags of 28-day emergency readmissions range
42 6 Discussion
between 0.4 and 0.5 for AMI and Hip Replacement, while year-long readmissions are not
persistent for either condition. The variation in short and long term readmissions varies
more considerably by condition. The standard deviation on both indicators is around
5% for AMI and Hip Replacement but ranges from between 10-2% for some of the other
conditions estimated.
The AMI model indicates a strong positive correlation between 28-day readmissions and
year-long readmissions, and weaker positive correlation between 30-day mortality and
year-long mortality. These associations are expected as they all represent worse outcomes.
However, the model also shows a negative association between mortality and readmissions
present for some conditions and diﬀerent time combinations, but strongest between year-
long mortality and year-long readmissions. McClellan and Staiger (1999) also observe this
result, for AMI, although for 30-day mortality and year-long readmissions. They note
that while a positive correlation might be expected, as higher values for both indicators
represent worse outcomes, the negative correlation may reflect the relatively poor heart
function of ‘marginal’ patients who survive when treated in high quality hospitals. Thus,
the hospitals which have worse mortality measures will perform better on the readmission
measures, as fewer severely ill patients survive to be readmitted. Moreover if healthier
patients led to low mortality rates, than complication rates for that hospital would also be
lower, thus there are quality diﬀerences amongst hospitals which are not linked to patient
selection.
The Hip Replacement model suggests mixed association between the readmission and
mortality variables; indicating a positive correlation between some of the mortality and
readmission combinations and negative correlations between the others. For example, 30-
day mortality is negatively associated with both short and long term readmissions but
year-long mortality has a positive association. In most of the conditions, all associations
are weak. However, for no condition were all associations positive, indicating that one
should be cautious when interpreting readmission measures in isolation as they may not
be indicative of higher quality. The results of the VAR models also report the correlation of
the residuals for the diﬀerent indicators. In all models short term and long term mortality
are positively correlated with one another, although in most cases this is very weak. Short
and long term readmissions have strong positive correlations with each other in the AMI
and Hip Replacement models, but very weak associations for most of the other conditions.
The signal variances estimated using the VAR parameters were also used together with
the estimation error to construct signal to noise ratios for each outcome measure in each
condition for the year 2005. The first striking result is how strong the signal is for the
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indicators in most conditions, for a suﬃcient sample of patients. While the number of cases
required to get a good signal to noise ratio varies by condition, in most cases it includes the
medium to large volume hospitals. McClellan and Staiger (1999) also observe this finding
in their paper, and note that it is generally harder to observe the true performance of
smaller hospitals from patient outcome data. This is because the variation in the data will
be more strongly influenced by diﬀerences in treatment, such as the presence or absence
of an individual physician, which would have relatively smaller eﬀects in a larger hospital.
Moreover, if we consider the average number of cases per hospital (Table 1) together with
the number of cases above which the signal to noise ratio because high enough, we see
that only for hospitals of average size and above do the patient outcome measures for a
single year provide relatively good information on performance.
The other striking result from the signal to noise ratios was that in all cases, except CCF,
long-term mortality had the strongest signal. This suggests that for these conditions, the
long term measure of mortality is a more useful measure of quality than the short term
measure. Similarly, for most conditions year-long readmissions had a stronger signal than
28-day readmissions, although this was not the case for Hip Replacement. Indeed 28-day
readmissions in almost all cases tended to be the worst performing measure. For cases
such as AMI, where treatment variations in the short term have high implications for
survival, one would expect the short term mortality measure to have a stronger signal.
Especially as long term outcomes add more noise. This finding was reported by McClellan
and Staiger (1999) in the US analysis. It is interesting that this is not the case in the UK
scenarios, and raises interesting questions as to why.
One possibility for the noise found in the short term estimates, may linked to the organiza-
tion of the health system and diﬀerent health policies within in the UK. In the NHS data
collection and reporting has not traditionally been attached to financing as it is in a claims
type system such as that of the US, this may lead to more error in estimates if less eﬀort
is put into coding. On the other hand, since 2000 many health policies have focused on
using measures such as 30-day in-hospital mortality and 28-day emergency readmissions
to measure and reward the performance of hospitals, such as the star ratings. There has
been criticism surrounding these policies and the distortionary results they had on indica-
tors, such as manipulation of data collection (Bevan and Hamblin, 2009). In addition, the
introduction of payment by results (2004/5) has now linked coding to hospital payments
changing the importance of good coding. As a result, discrepancies in coding practices
have been reported in the literature, such as hospitals coding deaths as palliative care in
order to reduce mortality rates (Hawkes, 2010). Thus, it is plausible that the emphasis
put on the short term indicators for policy has created more measurement error in their
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collection, making the longer term measures perform better despite the additional noise
in them from other exogenous factors such as patient behaviours and/or lifestyles.
The McClellan and Staiger (1999) analysis replicated the VAR models for diﬀerent samples
of hospitals in order to better understand the diﬀerences in estimation parameters between
them. We were unable to do this as the number of hospitals in our sample across each
of our conditions were considerably less, at around 100 per condition as opposed to their
sample of approximately 4,000.
While the results of the VAR models prove informative in themselves, they can also be
used to create ‘filtered measures’ of each of the four indicators. These filtered estimates
are able to encompass the time-series relationships within indicators, as well as the corre-
lations between measures, allowing them to portray a more accurate description of overall
performance. The results section presents these filtered measures together with the latent
measures in a series of diagrams for each outcome, for each condition. These figures have
three main similarities throughout all conditions. The first is that the filtered indicators
are able to provide smoother estimates over time as compared to the latent measures which
exhibit considerable year-to-year variation. The second is the wider confidence intervals
of the filtered measures, which are about double the size of the latent measure confidence
intervals. In their analysis, McClellan and Staiger (1999) note that the confidence inter-
vals for their filtered estimates are much tighter than those of the latent measures. We
attribute this diﬀerent finding to the smaller sample of hospitals we used to estimate the
filtered estimates, resulting in higher uncertainty surrounding the estimates4. However,
many critiques of the VAR methodology note that the standard errors of the variance de-
compositions are large that it is diﬃcult to make inferences about them (Sims, 1980). In
this instance as well, the wider confidence intervals make it much harder to draw conclusive
interpretations from the estimates about relative hospital performance.
Finally, the third similarity across conditions in the performance of the estimates for the
small hospitals. While the filtered estimates smooth out this performance, and have wide
confidence intervals, the latent measure will often lie outside these bounds. This reflects
observations noted earlier, about predicting performance for small hospitals, which the
raw measures are very sensitive to diﬀerences in treatment.
An evaluation of the filtered estimates in prediction the variation of true hospital eﬀects
is estimated through R-squared estimates, based on the adapted formula in McClellan
and Staiger (1999). The R-square estimates for all filtered measures, in all conditions,
4 Their sample consisted of 3945 hospitals while we had data on around 120 hospitals per condition.
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are very high, suggesting that the filtered estimates are able to predict true performance
remarkably well. These high estimates are in line with the very high signal to noise ratios
of the original data, discussed previously. Moreover, the R-squared measures also indicate
that the model is also able to predict very accurately using diﬀerent amounts of data,
including that of only one year. The R-squared values presented in this paper are much
higher than the ones reported byMcClellan and Staiger (1999), especially when using a
limited set of data to create predictions. This diﬀers from the McClellan and Staiger
results, where the R-squared estimates decline when a smaller sample is used to construct
the indicators. This is most probably related to diﬀerences in the underlying data. For
instance, unlike them, we had information on patient co-morbidity which allowed us to
better adjust for case-mix. Also while their sample only considered the elderly we looked
at the entire patient population.
As discussed previously, the VAR structure allows the model to forecast outcomes for
future years. By using the data to estimate performance the final years of our sample, and
compare these data to the true estimates we are able to assess how well the model forecasts
data. The R-squared results using this formula (equation (13)) were also very high for all
conditions, indicating the VAR’s ability to forecast outcomes. While these estimates are
again higher than McClellan and Staiger’s, they also note the model’s ability to forecast
extremely well. The results are also presented for a VAR(2) specification of the model, and
are almost identical to the VAR(1) results. This indicates that the forecast performance
is not sensitive to the lag choice specified in the VAR model.
The last section of this paper considers how hospitals perform when ranked by the three
diﬀerent measures (raw, latent and filtered). The results are quite striking. Depending
on the measure chosen, hospitals may go from the top of a ranking to the bottom, or the
opposite. The hospitals with the fewest cases are most influenced by the type of measure
as there is more variance in the raw and latent estimates. The filtered measures are better
at smoothing out the jumps from year to year as they combine all the information from
the time-series and across the other variables. Thus in these cases, the filtered measure
will be a better indication of performance in any one year. The latent estimates, while
risk adjusted are very erratic from year-to-year, and rankings may change suddenly when
looking at year snapshots. Raw measures do not control for exogenous characteristics that
influence outcomes, and so are the worst measure of the three. While the filtered estimates
are much better at providing a much more consistent picture of performance over time,
we do not advocate the ranking of hospitals, as this exercise shows how sensitive rankings
are to the method chosen.
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Much of the analysis of this paper focuses on identifying which indicators are more useful
for comparing performance across hospitals. The VAR models indicate which measures
are more persistent for the diﬀerent conditions, how much they vary across hospitals,
how well they capture the true signal in the data and how they are correlated with the
other measures being considered. The results overall suggest exercising caution when
interpreting any indicator alone as it may be misleading given its relationship with the
other outcome measures. However, the mortality indicators capture more of the true signal
than the readmission measures for most conditions, and especially long-term mortality
making it a better indicator to look at.
In conclusion, the analysis of the VAR models for the seven conditions chosen indicate
considerable correlation of the outcomes across time and between measures. The degree of
persistence varies by measure and across conditions, as does the extent to which measures
vary across hospitals. However, in almost all cases the most persistent measure with the
strongest signal was year-long mortality. Some of the other more generalizable findings are
that predictions are weaker for hospitals with fewer cases, and variation in their outcomes
from year to year is larger. However, measures overall are very good at identifying the true
signal of good performance in diﬀerent hospitals. Indeed the R-squared values indicate
that the measures are extremely good predictors and forecasters of performance.
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A Appendix: Comparison of Indicators
Tab. 9: Rankings of 2005 AMI D365ht measures.
Ranking Mean D365ht Hospital Latent D365ht Hospital Filtered D365ht Hospital
Top 10
1 0.087248 89 -10.9951 83 -3.58184 17
2 0.108949 55 -7.33457 119 -3.03305 54
3 0.113143 119 -7.01737 47 -2.52628 22
4 0.116531 52 -6.30999 42 -2.45368 3
5 0.123737 97 -5.81326 45 -2.3618 103
6 0.129032 62 -5.72524 15 -2.03254 18
7 0.141892 45 -5.43161 80 -2.01344 7
8 0.149923 112 -5.26463 91 -1.99536 107
9 0.150538 88 -4.79057 22 -1.79006 44
10 0.155303 19 -4.63651 62 -1.75694 40
Bottom 10
110 0.27566 21 4.33436 21 0.998402 114
111 0.276094 76 4.432666 90 1.038727 41
112 0.276423 61 4.860979 96 1.257631 38
113 0.285 53 4.952693 53 1.294286 33
114 0.291228 41 4.981547 36 1.342004 35
115 0.29912 96 5.641765 107 1.400486 99
116 0.306338 71 7.110268 10 1.55153 66
117 0.312139 3 7.266694 3 2.121651 27
118 0.4 66 7.715625 71 2.203174 9
119 0.426573 43 18.70868 43 2.538532 56
Tab. 10: Rankings of 2005 AMI R28ht measures.
Ranking Mean R28ht Hospital Latent R28ht Hospital Filtered R28ht Hospital
Top 10
1 0 66 -17.15334 66 -0.5097684 56
2 0.0410959 80 -13.77112 83 -0.4249609 27
3 0.0537634 62 -9.429364 62 -0.4037885 9
4 0.0758123 57 -7.974833 80 -0.3244067 38
5 0.0769231 43 -6.535955 43 -0.2796607 99
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Ranking Mean R28ht Hospital Latent R28ht Hospital Filtered R28ht Hospital
6 0.0824373 88 -4.354861 57 -0.2724753 41
7 0.0873786 113 -3.504739 113 -0.2207526 116
8 0.09375 36 -3.356516 36 -0.2168493 33
9 0.0989209 63 -2.987282 88 -0.1949843 35
10 0.0990415 51 -2.770071 45 -0.1943502 53
Bottom 10
110 0.1564246 85 3.137839 23 0.5282587 83
111 0.1594203 27 3.158059 6 0.5671023 107
112 0.1598916 14 3.614229 27 0.5836549 106
113 0.1601423 23 3.619557 72 0.589515 40
114 0.1606061 16 3.697118 9 0.5981762 3
115 0.1615721 59 4.066902 14 0.6017366 18
116 0.164486 6 4.984622 46 0.7226745 22
117 0.1715976 9 5.005144 16 0.7290823 103
118 0.1856061 19 5.010148 19 0.8328696 17
119 0.1933962 46 5.822222 59 0.8452681 54
Tab. 11: Rankings of 2005 AMI R365ht measures.
Ranking Mean R365ht Hospital Latent R365ht Hospital Filtered R365ht Hospital
Top 10
1 0.118881 43 -12.698 43 -0.6166016 56
2 0.167785 89 -12.05263 83 -0.5771485 33
3 0.169675 57 -7.481782 62 -0.4943517 99
4 0.172043 62 -7.190022 89 -0.483924 38
5 0.172524 51 -5.687592 113 -0.4257711 116
6 0.181004 88 -5.204206 33 -0.3740641 9
7 0.182222 99 -4.925087 99 -0.3105961 62
8 0.18932 113 -4.808173 51 -0.2949201 66
9 0.197425 33 -4.342741 88 -0.2844733 41
10 0.200557 102 -4.314243 58 -0.2767854 118
Bottom 10
110 0.278986 27 4.798292 95 0.4114325 5
111 0.280397 78 4.828352 28 0.4298307 67
112 0.283951 72 4.928086 80 0.4988003 3
113 0.284734 95 5.156519 72 0.5044565 50
49
Ranking Mean R365ht Hospital Latent R365ht Hospital Filtered R365ht Hospital
114 0.285266 86 5.201916 23 0.5073113 77
115 0.288256 23 5.52123 71 0.5493379 18
116 0.292254 71 5.75459 11 0.5793964 17
117 0.292553 11 5.975807 4 0.6079986 40
118 0.301887 46 7.396799 46 0.6340984 106
119 0.4 66 19.4526 66 0.6462436 54
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